发明名称 Tetracycline compositions
摘要 The present invention relates to compositions, pharmaceutical compositions, and methods for preparing the same, comprising a tetracycline with improved stability and solubility. Some embodiments include a tetracycline with an excess of a divalent or trivalent cation.
申请公布号 US9084802(B2) 申请公布日期 2015.07.21
申请号 US201414204881 申请日期 2014.03.11
申请人 REMPEX PHARMACEUTICALS, INC. 发明人 Griffith David C.;Boyer Serge;Hecker Scott;Dudley Michael N.
分类号 A01N47/00;A61K31/21;A61K31/65;A61K9/00;A61K47/02 主分类号 A01N47/00
代理机构 Knobbe Martens Olson & Bear LLP 代理人 Knobbe Martens Olson & Bear LLP
主权项 1. A method of treating a bacterial infection in a subject, wherein the method consists of: administering a therapeutically effective amount of a composition to a subject in need thereof via an intravenous route of administration, wherein the composition consists of an aqueous solution consisting of minocycline or a salt thereof, a salt that comprises a magnesium cation, and a base, wherein the molar ratio of magnesium cation to minocycline is greater than about 4:1, and wherein the composition has a pH that is no less than 4 and no greater than 6, whereby injection site hemolysis of red blood cells is reduced relative to intravenous administration of a composition that does not include magnesium.
地址 San Diego CA US